Search

Your search keyword '"Mazidi, Mohsen"' showing total 220 results

Search Constraints

Start Over You searched for: Author "Mazidi, Mohsen" Remove constraint Author: "Mazidi, Mohsen" Publication Year Range Last 3 years Remove constraint Publication Year Range: Last 3 years
220 results on '"Mazidi, Mohsen"'

Search Results

2. Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations

4. Prevalence of statin intolerance: a meta-analysis

6. Conventional and genetic associations of adiposity with 1463 proteins in relatively lean Chinese adults

7. Step-by-step diagnosis and management of the nocebo/drucebo effect in statin-associated muscle symptoms patients: a position paper from the International Lipid Expert Panel (ILEP).

8. One-size-fits-all versus risk-category-based screening interval strategies for cardiovascular disease prevention in Chinese adults: a prospective cohort study

10. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

11. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

12. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

13. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

14. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

15. Association between health insurance cost-sharing and choice of hospital tier for cardiovascular diseases in China: a prospective cohort study

16. Causal association between snoring and stroke: a Mendelian randomization study in a Chinese population

17. A wide landscape of morbidity and mortality risk associated with marital status in 0.5 million Chinese men and women: a prospective cohort study

18. Long-Term Exposure to Fine Particulate Matter and Incidence of Esophageal Cancer: A Prospective Study of 0.5 Million Chinese Adults

19. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

21. Tobacco smoking and risks of more than 470 diseases in China: a prospective cohort study

25. Proteo-genomic analyses in relatively lean Chinese adults identify proteins and pathways that affect general and central adiposity levels.

26. The Role of Furin and Its Therapeutic Potential in Cardiovascular Disease Risk.

29. Diet and lifestyle behaviour disruption related to the pandemic was varied and bidirectional among US and UK adults participating in the ZOE COVID Study

30. Proteomic analyses in diverse populations improved risk prediction and identified new drug targets for type 2 diabetes

31. Association between health insurance cost-sharing and choice of hospital tier for cardiovascular diseases in China: a prospective cohort study

32. Causal association between snoring and stroke: a Mendelian randomization study in a Chinese population

34. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021

35. Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021

36. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

37. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

38. Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021

39. Proteomic Analyses in Diverse Populations Improved Risk Prediction and Identified New Drug Targets for Type 2 Diabetes.

41. Global Burden of Cardiovascular Diseases and Risks, 1990-2022

42. Proteomic aging clock predicts mortality and risk of common age-related diseases in diverse populations

43. Long-Term Exposure to Fine Particulate Matter and Incidence of Esophageal Cancer: A Prospective Study of 0.5 Million Chinese Adults

45. A systematic review and meta-analysis of randomized controlled trials to evaluate plant-based omega-3 polyunsaturated fatty acids in nonalcoholic fatty liver disease patient biomarkers and parameters.

46. Maternal High Fat Diet in Lactation Impacts Hypothalamic Neurogenesis and Neurotrophic Development, Leading to Later Life Susceptibility to Obesity in Male but Not Female Mice.

47. Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

48. Plasma Proteomics to Identify Drug Targets for Ischemic Heart Disease.

49. Psychological Stress and Gut Microbiota Composition: A Systematic Review of Human Studies.

Catalog

Books, media, physical & digital resources